COMP <GO>
ANVS vs BMEA // EV/EBITDA & P/E VALUATION
Annovis Bio Inc. (NYSE) VS. Biomea Fusion Inc. (NASDAQ) • 15-METRIC TALLY: ANVS 1
— BMEA 2
■ METRIC PARITY
LAST: $1.02 (0.00%) • MKT CAP: $43.5M
valuation
—
LAST: $0.62 (-3.84%) • MKT CAP: $45.1M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANVS VS. BMEA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANVS | BMEA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | BMEA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 27.7 | +23.96 | ANVS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $43.5M | $45.1M | -$1.6M | BMEA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANVS REV | BMEA REV | ANVS GROSS % | BMEA GROSS % | ANVS FCF | BMEA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$25.6M | -$70.4M |
| FY 2024 | $0 | $0 | — | — | -$21.9M | -$120.3M |
| FY 2023 | $0 | $0 | — | — | -$40.0M | -$96.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANVS // BETA —
BMEA // BETA —